Alta Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-5,958
Closed -$221K – 96
2019
Q4
$221K Hold
5,958
– – 0.01% 85
2019
Q3
$203K Hold
5,958
– – 0.01% 91
2019
Q2
$244K Hold
5,958
– – 0.01% 87
2019
Q1
$240K Hold
5,958
– – 0.01% 86
2018
Q4
$246K Hold
5,958
– – 0.02% 77
2018
Q3
$249K Sell
5,958
-344
-5% -$13.2K 0.01% 77
2018
Q2
$216K Hold
6,302
– – 0.01% 76
2018
Q1
$212K Hold
6,302
– – 0.01% 75
2017
Q4
$216K Hold
6,302
– – 0.01% 69
2017
Q3
$213K Sell
6,302
-785
-11% -$25.2K 0.01% 80
2017
Q2
$225K Sell
7,087
-580
-8% -$18.3K 0.02% 80
2017
Q1
$248K Sell
7,667
-240
-3% -$7.57K 0.02% 77
2016
Q4
$243K Hold
7,907
– – 0.02% 83
2016
Q3
$254K Hold
7,907
– – 0.02% 84
2016
Q2
$264K Sell
7,907
-206
-3% -$6.58K 0.02% 83
2016
Q1
$228K Hold
8,113
– – 0.01% 100
2015
Q4
$248K Sell
8,113
-552
-6% -$17.4K 0.02% 99
2015
Q3
$258K Buy
+8,665
New +$278K 0.02% 101

Other funds holding PFE

Alta Capital Management's PFE Position: Q1 2020 in Review

Alta Capital Management sold out of Pfizer (PFE) in Q1 2020, closing a stake of 5,958 shares — an estimated $221K sold.

Alta Capital Management first reported a position in PFE in Q3 2015 and held it in 18 quarters. The position peaked at $264K in Q2 2016. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Alta Capital Management reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
  • Alta Capital Management sold 5,958 Pfizer shares in Q1 2020, an estimated $221K.
  • Alta Capital Management first reported a position in Pfizer in Q3 2015 and held it in 18 quarters.
  • Alta Capital Management's Pfizer position peaked at $264K in Q2 2016.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Alta Capital Management's 13F filing for Q1 2020, filed 6 May 2020.